CSP
14 min read
20

Strong biological performance in the Faroe Islands and successful de-risking in Scotland

November 5, 2024
0

Reading Time: 10 minutes The Bakkafrost Group delivered a total operational EBIT of DKK 173 million (DKK 269 million) in Q3 2024. (Figures in parenthesis refer to the same period last year unless otherwise specified) The performance in Q3 2024 per region was as follows:

Continue Reading
Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei
BWI
3 min read
36

Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei

November 5, 2024
0

Reading Time: 2 minutes Seattle, United States:   Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch and availability of Evercode™ Low Input Fixation kits for both cells and nuclei. The new kits empower researchers who have a

Continue Reading
CSP
1 min read
34

Fondia Plc: Share repurchase 4.11.2024

November 4, 2024
0

Reading Time: < 1 minute Fondia Plc Company release 4.11.2024 at 6.45 p.m. EET   Fondia – Acquisition of own shares 4.11.2024   Fondia Plc   First North Finland   Date 4.11.2024 Exchange transactions Buy Share class FONDIA Amount, shares 241 Average price/share, EUR 5,981120

Continue Reading
CSP
4 min read
41

Etrion Releases Third Quarter 2024 Results

November 4, 2024
0

Reading Time: 3 minutes November 4, 2024, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”, and, together with its subsidiaries, the “Group”) released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and nine months ended

Continue Reading
Neste, Alterra and Technip Energies collaborate to offer standardized solution to build chemical recycling plants
CSP
5 min read
37

Neste, Alterra and Technip Energies collaborate to offer standardized solution to build chemical recycling plants

November 4, 2024
0

Reading Time: 4 minutes Neste Corporation, Press Release, 4 November 2024 at 7.00 p.m. (EET) Photo: Alterra’s Akron Plant in Ohio, 2024. Source: Alterra The partners aim to globally offer a standardized modular solution, based on Alterra’s proprietary discarded plastic liquefaction technology, to parties interested

Continue Reading
ABS Showcases Commitment to Saudi Maritime Industry at Saudi Maritime & Logistics Congress
CSP
2 min read
38

ABS Showcases Commitment to Saudi Maritime Industry at Saudi Maritime & Logistics Congress

November 4, 2024
0

Reading Time: 2 minutes ABS demonstrated its commitment to the Saudi maritime industry during the recent Saudi Maritime & Logistics Congress at the Dhahran Expo in Dammam, Saudi Arabia. The event showcased the potential of Saudi Arabia as a burgeoning hub for the maritime sector

Continue Reading
CSP
3 min read
14

Communique from the EXTRAORDINARY General Meeting OF SHAREHOLDERS in Eevia Health Plc

November 4, 2024
0

Reading Time: 3 minutes The Extraordinary General Meeting of Shareholders of Eevia Health Plc, corp. Reg. No 2825194-4 (the “Company”) was held on November 4, 2024, in Seinäjoki, Finland, whereby the shareholders primarily resolved the following matters.   For immediate release Seinäjoki, Finland, November 4,

Continue Reading
CSP
1 min read
12

Notification under Chapter 9, Section 10 of the Finnish Securities Market Act

November 4, 2024
0

Reading Time: < 1 minute Neste Corporation, Stock Exchange Release, 4 November 2024 at 7.30 p.m. (EET) Neste Corporation has today received a notification under Chapter 9, Section 10 of the Finnish Securities Market Act (FSMA). According to the notification, the aggregate holdings including financial instruments according to SMA 9:6a

Continue Reading
CSP
2 min read
21

KONE Corporation: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

November 4, 2024
0

Reading Time: 2 minutes KONE Corporation, stock exchange release, November 4, 2024 at 07:00 p.m. EET KONE Corporation: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 KONE Corporation has received an announcement from BlackRock, Inc. on November 4, 2024, in accordance with the Finnish

Continue Reading
CSP
1 min read
22

BioStock: Medivir signs new clinical trial collaboration with Eisai

November 4, 2024
0

Reading Time: < 1 minute Mon, Nov 04, 2024 16:41 CET Report this content Medivir has entered into a clinical trial collaboration and supply agreement with Eisai to evaluate its liver-targeted treatment, fostrox, in combination with lenvatinib for advanced liver cancer. This partnership

Continue Reading